[en] During osmotic demyelination syndrome (ODS), myelin and oligodendrocyte are lost according to specific patterns in centro- or extra-pontine regions. In both experimental model of ODS and human cases, brain lesions are locally correlated with the disruption of the blood brain-barrier (BBB). The initiation, the degree and the duration of blood-brain barrier (BBB) opening as well as its contribution to brain damages are still a matter of debate. Using a panel of intravascular tracers from low- to high- molecular weight (from 0.45 kDa 150 kDa), we have assessed the BBB permeability at different timings of ODS induced experimentally in mice. ODS was mimicked according to a protocol of rapid correction of a chronic hyponatremia. We demonstrated that BBB leakage towards smallest tracers Lucifer Yellow (0.45 kDa) and Texas Red-dextran (3 kDa) was delayed by 36 h compared to the first clues of oligodendrocyte loss (occurring 12 h post-correction of hyponatremia). At 48 h post-correction and concomitantly to myelin loss, BBB was massively disrupted as attested by accumulation of Evans Blue (69 kDa) and IgG (150 kDa) in brain parenchyma. Analysis of BBB ultrastructure verified that brain endothelial cells had minimal alterations during chronic hyponatremia and at 12 h post-correction of hyponatremia. However, brain endothelium yielded worsened alterations at 48 h, such as enlarged vesicular to tubular-like cytoplasmic profiles of pinocytosis and/or transcytosis, local basal laminae abnormalities and sub-endothelial cavities. The protein expressions of occludin and claudin-1, involved in inter-endothelial tight junctions, were also downregulated at 48 h post-correction of hyponatremia. Our results revealed that functional BBB opening occured late in pre-established ODS lesions, and therefore was not a primary event initiating oligodendrocyte damages in the mouse model of ODS.
Gilloteaux, Jacques; URPhyM - NARILIS, Université de Namur, Namur, Belgium, Department of Anatomical Sciences, St George's University School of Medicine, Newcastle upon Tyne, United Kingdom. Electronic address: jacques.gilloteaux@unamur.be
Kleinschmidt-DeMasters, B.K., Norenberg, M.D., Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science 211 (1981), 1068–1070.
Norenberg, M.D., Leslie, K.O., Robertson, A.S., Association between rise in serum sodium and central pontine myelinolysis. Ann. Neurol. 11 (1982), 128–135.
Gankam Kengne, F., Nicaise, C., Soupart, A., Boom, A., Schiettecatte, J., Pochet, R., Brion, J.P., Decaux, G., Astrocytes are an early target in osmotic demyelination syndrome. J. Am. Soc. Nephrol. 22 (2011), 1834–1845.
Gankam-Kengne, F., Couturier, B.S., Soupart, A., Brion, J.P., Decaux, G., Osmotic stress-induced defective glial proteostasis contributes to brain demyelination after hyponatremia treatment. J. Am. Soc. Nephrol. 28 (2017), 1802–1813.
Popescu, B.F., Bunyan, R.F., Guo, Y., Parisi, J.E., Lennon, V.A., Lucchinetti, C.F., Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathol. Commun., 1, 2013, 40.
Takagi, H., Sugimura, Y., Suzuki, H., Iwama, S., Izumida, H., Fujisawa, H., Ogawa, K., Nakashima, K., Ochiai, H., Takeuchi, S., Kiyota, A., Suga, H., Goto, M., Banno, R., Arima, H., Oiso, Y., Minocycline prevents osmotic demyelination associated with aquaresis. Kidney Int. 86 (2014), 954–964.
Alleman, A.M., Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis. Semin. Ultrasound CT MR 35 (2014), 153–159.
Sterns, R.H., Adverse consequences of overly-rapid correction of hyponatremia. Front. Horm. Res. 52 (2019), 130–142.
Adler, S., Martinez, J., Williams, D.S., Verbalis, J.G., Positive association between blood brain barrier disruption and osmotically-induced demyelination. Mult. Scler. 6 (2000), 24–31.
Adler, S., Verbalis, J.G., Williams, D., Effect of rapid correction of hyponatremia on the blood-brain barrier of rats. Brain Res. 679 (1995), 135–143.
Baker, E.A., Tian, Y., Adler, S., Verbalis, J.G., Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia. Exp. Neurol. 165 (2000), 221–230.
Rojiani, A.M., Prineas, J.W., Cho, E.S., Electrolyte-induced demyelination in rats. 1. Role of the blood-brain barrier and edema. Acta Neuropathol. 88 (1994), 287–292.
Gankam Kengne, F., Soupart, A., Pochet, R., Brion, J.P., Decaux, G., Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int. 76 (2009), 614–621.
Sugimura, Y., Murase, T., Takefuji, S., Hayasaka, S., Takagishi, Y., Oiso, Y., Murata, Y., Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp. Neurol. 192 (2005), 178–183.
Bradl, M., Lassmann, H., Oligodendrocytes: biology and pathology. Acta Neuropathol. 119 (2010), 37–53.
Bamm, V.V., Lanthier, D.K., Stephenson, E.L., Smith, G.S., Harauz, G., In vitro study of the direct effect of extracellular hemoglobin on myelin components. Biochim. Biophys. Acta 1852 (2015), 92–103.
Ruijs, T.C., Olivier, A., Antel, J.P., Serum cytotoxicity to human and rat oligodendrocytes in culture. Brain Res. 517 (1990), 99–104.
Gankam-Kengne, F., Soupart, A., Pochet, R., Brion, J.P., Decaux, G., Minocycline protects against neurologic complications of rapid correction of hyponatremia. J. Am. Soc. Nephrol. 21 (2010), 2099–2108.
Bouchat, J., Couturier, B., Marneffe, C., Gankam-Kengne, F., Balau, B., De Swert, K., Brion, J.P., Poncelet, L., Gilloteaux, J., Nicaise, C., Regional oligodendrocytopathy and astrocytopathy precede myelin loss and blood-brain barrier disruption in a murine model of osmotic demyelination syndrome. Glia 66 (2018), 606–622.
Bouchat, J., Gilloteaux, J., Suain, V., Van Vlaender, D., Brion, J.P., Nicaise, C., Ultrastructural analysis of thalamus damages in a mouse model of osmotic-induced demyelination. Neurotox. Res. 36 (2019), 144–162.
Gilloteaux, J., Bouchat, J., Brion, J.P., Nicaise, C., The osmotic demyelination syndrome: the thalamic neurons resilience is verified with electron microscopy. Ultrastruct. Pathol., 44, 2020.
Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., Pochet, R., Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 1301 (2009), 152–162.
Soyfoo, M.S., Konno, A., Bolaky, N., Oak, J.S., Fruman, D., Nicaise, C., Takiguchi, M., Delporte, C., Link between inflammation and aquaporin-5 distribution in submandibular gland in Sjogren's syndrome?. Oral Dis 18 (2012), 568–574.
Nag, S., Ultracytochemical studies of the compromised blood-brain barrier. Methods Mol. Med. 89 (2003), 145–160.
Simionescu, M., Simionescu, N., Palade, G.E., Morphometric data on the endothelium of blood capillaries. J. Cell Biol. 60 (1974), 128–152.
Clough, G., Relationship between microvascular permeability and ultrastructure. Prog. Biophys. Mol. Biol. 55 (1991), 47–69.
Nicaise, C., Marneffe, C., Bouchat, J., Gilloteaux, J., Osmotic demyelination: from an oligodendrocyte to an astrocyte perspective. Int. J. Mol. Sci., 20, 2019.
Yang, A.C., Stevens, M.Y., Chen, M.B., Lee, D.P., Stähli, D., Gate, D., Contrepois, K., Chen, W., Iram, T., Zhang, L., Vest, R.T., Chaney, A., Lehallier, B., Olsson, N., du Bois, H., Hsieh, R., Cropper, H.C., Berdnik, D., Li, L., Wang, E.Y., Traber, G.M., Bertozzi, C.R., Luo, J., Snyder, M.P., Elias, J.E., Quake, S.R., James, M.L., Wyss-Coray, T., Physiological blood-brain transport is impaired with age by a shift in transcytosis. Nature 583 (2020), 425–430.
Abbott, N.J., Inflammatory mediators and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 20 (2000), 131–147.
Lossinsky, A.S., Shivers, R.R., Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Rev. Histol. Histopathol. 19 (2004), 535–564.
Villaseñor, R., Lampe, J., Schwaninger, M., Collin, L., Intracellular transport and regulation of transcytosis across the blood-brain barrier. Cell. Mol. Life Sci.: CMLS 76 (2019), 1081–1092.
